7 Hills Pharma LLC

Hall A, Booth 137
Houston, Texas, United States
7 Hills Pharma is an immunotherapy company developing novel small molecules to improve the effectiveness of immune checkpoint inhibitors for cancer and vaccines for infectious diseases. Our lead compound, 7HP349, is a first-in-concept integrin activator that stabilizes cell-cell interactions required for antigen presentation. 7HP349 improves the effectiveness of immune checkpoint inhibitors for cancer, as well as vaccines for Influenza, Tuberculosis, Coronavirus and Chagas disease. 7HP349 is the only systemically safe adjuvant that can activate both cellular and humoral immunity.
Latest Announcements
Congratulations to the Buzz of BIO winners!
Start-Up Stadium provides an exciting and interactive experience where key stakeholders of the early-stage life science community, investors, and…
Voting for the Buzz of BIO contest is now closed. Winners will be announced on March 24. The contest provides visibility for companies looking to…